| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/03/2011 | US20110052557 Phytocomposition having antimicrobial activity |
| 03/03/2011 | US20110052544 Novel bacteriophage and antibacterial composition comprising the same |
| 03/03/2011 | US20110052543 Novel bacteriophage and antibacterial composition comprising the same |
| 03/03/2011 | US20110052542 Novel bacteriophage and antibacterial composition comprising the same |
| 03/03/2011 | US20110052541 Novel bacteriophage and antibacterial composition comprising the same |
| 03/03/2011 | US20110052536 Methods of treating a flaviviridae family viral infection and compositions for treating a flaviviridae family viral infection |
| 03/03/2011 | US20110052534 Imidazopyridazine Compounds for Treating Viral Infections |
| 03/03/2011 | US20110052532 Pharmaceutical composition comprising a cytokine |
| 03/03/2011 | US20110052525 Breaking Immunological Tolerance with a Genetically Encoded Unnatural Amino Acid |
| 03/03/2011 | US20110052519 Peptide derivatives useful in the treatment, care or cleansing of the skin, mucosae, scalp or nails |
| 03/03/2011 | US20110052506 Stable Aerosol Topical Foams Comprising a Hypochlorite Salt |
| 03/03/2011 | DE102009038634A1 Agent, useful e.g. for adjuvant therapy of AIDS diseases, HIV-1 or HIV-2 disease, comprises silicate mineral and optionally further materials |
| 03/03/2011 | DE102009037089A1 Zusammensetzung mit Stämmen von Lactobazillus fermentum Composition with Lactobacillus fermentum strains of |
| 03/03/2011 | CA2778225A1 Anti-bacterial compositions comprising extracts of eremophila longifolia and methods for use of same |
| 03/03/2011 | CA2772386A1 Tetracycline compounds |
| 03/03/2011 | CA2771933A1 Bisphosphonates as inhibitors of acid sphingomyelinase |
| 03/03/2011 | CA2771044A1 Aralkyl benzyl ethers compounds, process for preparation thereof, intermediate compounds, use of such compounds, methods of treatment and/or prevention, pharmaceutical compositionand medicine containing the same |
| 03/03/2011 | CA2770338A1 Processes for preparing protease inhibitors of hepatitis c virus |
| 03/03/2011 | CA2769751A1 Picrorhiza kurroa extract for prevention, elimination and treatment of dna based viruses in humans and in biotech industry |
| 03/02/2011 | EP2290083A1 Conserved neisserial antigens |
| 03/02/2011 | EP2289970A1 Biocompatible polymers, their process of manufacture and compositions containing them |
| 03/02/2011 | EP2289938A2 Use of Panton-Valentine Leukocidin for treating and preventing staphylococcus infections |
| 03/02/2011 | EP2289904A1 Inhibitors of microbial infections |
| 03/02/2011 | EP2289900A1 Bisphosphonates as inhibitors of acid sphingomyelinase |
| 03/02/2011 | EP2289871A1 7-substituted tetracycline compounds |
| 03/02/2011 | EP2289599A2 Compositions comprising neisseria meningitidis antigens from serogroups B and C |
| 03/02/2011 | EP2289551A1 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/02/2011 | EP2289550A2 Ultra high affinity neutralizing antibodies |
| 03/02/2011 | EP2289549A2 Immunoconjugates for treating cancer |
| 03/02/2011 | EP2289548A2 Combined vaccines comprising hepatitis B surface antigen and other antigens |
| 03/02/2011 | EP2289545A2 Supplemented OMV vaccine against meningococcus |
| 03/02/2011 | EP2289520A1 Use of acetylsalicylic acid for the prophylaxis and/or treatment of influenza virus infection. |
| 03/02/2011 | EP2289516A1 Methods and means for the treatment of HPV induced intraepithelial neoplasias |
| 03/02/2011 | EP2289506A2 Medicament comprising a C11-C21 alkanoic, alkenoic or alkynoic acid ester and a catechin |
| 03/02/2011 | EP2289503A2 Treating muscle wasting with selective androgen receptor modulators |
| 03/02/2011 | EP2288414A1 Anhydrous and hydrate forms of crystalline 2- ( (2s, 3r, 4e, 6e, 1oe, 12s) -13- (4-fluorophenoxy) -2,3, 12- (trihydroxytrideca-4, 6, 10-trien-8-ynyl) oxy) acetic acid |
| 03/02/2011 | EP2288363A1 Plant extract and its therapeutic use |
| 03/02/2011 | EP2288361A1 Cistus extract containing enriched secondary plant ingredients |
| 03/02/2011 | EP2288359A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents |
| 03/02/2011 | EP2288357A1 Compositions comprising red microalgae polysaccharides and metals |
| 03/02/2011 | EP2288346A1 Oral compositions containing enhanced antibacterial combinations of antioxidants and extracts of magnolia |
| 03/02/2011 | EP2097423B1 Aminothiazole macrocycles, their use as antibacterial compounds and processes for their production |
| 03/02/2011 | EP2040712B1 Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines |
| 03/02/2011 | EP1831174B1 Amide derivatives |
| 03/02/2011 | EP1673385B1 Macrocyclic peptides active against the hepatitis c virus |
| 03/02/2011 | EP1650225B1 Hetero type pentamer recombinant vaccine |
| 03/02/2011 | EP1423101B1 Use of a plaster for the treatment of onychomycoses |
| 03/02/2011 | EP1368456B1 Anti-bacterial vaccine compositions |
| 03/02/2011 | EP1363663B1 Nucleic acid mucosal immunization |
| 03/02/2011 | EP1185662B1 Dna vaccines for dogs |
| 03/02/2011 | EP1064942B9 Sustained release preparation of a macrolide |
| 03/02/2011 | CN1939916B Compound for treating AIDS |
| 03/02/2011 | CN1674935B Biofunctional composition containing CpG or oligo-/polynucleotide and toxin or enterotoxin |
| 03/02/2011 | CN1646157B Multiple and multivalent DNA vaccines in ovo |
| 03/02/2011 | CN101983063A Anti-infective agents and uses thereof |
| 03/02/2011 | CN101982468A Novel oxazolidinone derivatives and pharmaceutical compositions comprising the derivatives |
| 03/02/2011 | CN101982462A Compound separated and extracted by marine fusarium and application thereof |
| 03/02/2011 | CN101982200A Rhizoma coptidis total alkaloids resin complexes, sustained-release preparation thereof and preparation method thereof |
| 03/02/2011 | CN101982198A Perfusion medicinal oil for treating hysteritis of cow and preparation method thereof |
| 03/02/2011 | CN101982193A Traditional Chinese medicine composition for treating pulmonary tuberculosis, preparation method and application thereof |
| 03/02/2011 | CN101982190A External cream for treating wind cold by utilizing percutaneous absorption technology |
| 03/02/2011 | CN101982188A Application of Tangut dragonhead in preparation of drugs for treating livestock and poultry viral infectious diseases |
| 03/02/2011 | CN101982187A Walnut shell extract and anti-HIV pharmaceutical application thereof |
| 03/02/2011 | CN101982185A Radish seed extract as well as preparation method and application of radish seed extract |
| 03/02/2011 | CN101982179A Xiao er Anfen Huang Namin granule and preparation method thereof |
| 03/02/2011 | CN101982176A Compound sodium selenite-vitamin E oral nano-emulsion preparation for livestock and preparation method thereof |
| 03/02/2011 | CN101982173A Danofloxacin mesylate-amoxicillinsuspension injection applicable to livestock and poultry as well as preparation and application thereof |
| 03/02/2011 | CN101982171A Application of fenugreek biflavone glycosides for preparing anti-virus or/and anti-tumor drugs |
| 03/02/2011 | CN101982167A Butoconazole nitrate suppository used in gynaecology, preparation method and application thereof |
| 03/02/2011 | CN101982166A Slow release formulation of moxifloxacin and preparation method thereof |
| 03/02/2011 | CN101543488B A medicine containing caffeic acid 3,4-dihydroxyl phenethyl ester and its uses |
| 03/02/2011 | CN101199449B Application of hyamine antibiont on dentistry antibacterial replacement material |
| 03/02/2011 | CN101104604B Optically pure dihydropyrimidine compounds and use for the same in preparing medicament for curing and preventing virosis |
| 03/01/2011 | US7897757 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 03/01/2011 | US7897729 Polymeric immunoglobulin fusion proteins that target low affinity FcγReceptors |
| 03/01/2011 | US7897635 HIV protease inhibitors |
| 03/01/2011 | US7897593 HIV integrase inhibitors |
| 03/01/2011 | US7897592 HIV integrase inhibitors |
| 03/01/2011 | US7897590 Methods to mobilize progenitor/stem cells |
| 03/01/2011 | US7897387 Fungal cell wall synthesis gene |
| 03/01/2011 | US7897346 Polyamide nucleic acid derivatives and agents, and processes for preparing them |
| 03/01/2011 | US7897343 Propagating attenuated lelystad agent in host cells for use in generating vaccine for prevention and treatment of procine respiratory infection |
| 03/01/2011 | US7897180 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 03/01/2011 | US7897158 Recombinant toxin fragments |
| 03/01/2011 | US7897156 Modified vaccinia virus ankara for the vaccination of neonates |
| 03/01/2011 | US7897152 Viral chemokine-antigen fusion proteins |
| 03/01/2011 | CA2411660C Enzyme-cleavable prodrug compounds |
| 03/01/2011 | CA2348488C Novel agents and methods for treatment and diagnosis of ocular disorders |
| 02/24/2011 | WO2011022725A2 Mimotopes of hiv and uses thereof |
| 02/24/2011 | WO2011022509A2 Substituted benzoazepines as toll-like receptor modulators |
| 02/24/2011 | WO2011022508A2 Substituted benzoazepines as toll-like receptor modulators |
| 02/24/2011 | WO2011021678A1 Fused heterocyclic compound |
| 02/24/2011 | WO2011021508A1 Marker for predicting therapeutic effect on hepatitis c, method for predicting therapeutic effect on hepatitis c, and prophylaxis or therapeutic agent for hepatitis c |
| 02/24/2011 | WO2011021503A1 Pharmaceutical composition containing transiently surviving ctl |
| 02/24/2011 | WO2011020957A1 Antibacterial food composition |
| 02/24/2011 | WO2011020822A1 Substituted (thiazolyl-carbonyl)imidazolidinones and use thereof for treating retroviral diseases |
| 02/24/2011 | WO2011020605A1 Process for the production of coevaporates and complexes comprising voriconazole and cyclodextrin |
| 02/24/2011 | WO2010132757A3 Antibacterial aminoglycoside analogs |
| 02/24/2011 | WO2010115172A3 Antigenic peptide of hsv-2 and methods for using same |
| 02/24/2011 | WO2010096719A3 Anticancer and antimicrobial compounds from antarctic extremophilic microorganisms |